What is A-T? • Ataxia-telangiectasia (A-T)... - is a rare genetic disease - attacks in early childhood - progressively affects coordination - predisposes patients to fatal cancers - severely compromises the immune system • Children with A-T are... - as rare as one in 40,000 births - from all races and ethnicities - usually unable to walk by age 10 and rarely survive their teens • Carriers of mutated copies of the A-T gene are approximately one per 100 individuals in the general population. • Compared to the typical population, the cancer rate of children with A-T is 1,000 times higher, and the cancer rate of carriers can be up to four times higher. The Ataxia Telangiectasia Children's Project, better known as the A-T Children's Project, is a public nonprofit organization with a 501(c)(3) tax exempt determination by the Internal Revenue Service. The A-T Children's Project was formed in 1993 to raise funds to support and coordinate first-rate biomedical research projects, scientific conferences and the A-T Clinical Center at Johns Hopkins Hospital in Baltimore, Maryland aimed at finding a cure or life-improving therapies for A-T. The A-T Children's Project is predominantly funded by the grassroots efforts of families and friends of children with A-T. For every dollar donated to A-T, 87 cents is allocated directly to funding research. For more information please visit www.atcp.org.